Drug Discovery - Medicine.net

Experimental compound curbs alcohol intake and motivation in mice, with sex-dependent differences

Updated on: December 19,2025

Experimental compound curbs alcohol intake and motivation in mice, with sex-dependent differences

Updated on:December 19,2025

What happens when you donate your brain to science?

Updated on: December 23,2025

What happens when you donate your brain to science?

Updated on:December 23,2025

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat

Updated on: January 23,2026

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat

Updated on:January 23,2026

$FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma$

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

Updated on: December 27,2025

$FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma$

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

Updated on:December 27,2025